Literature DB >> 5933055

A preliminary study of human calcium metabolism using long-term whole body tracer measurements.

J E Harrison, K G McNeill, J M Finlay, R H Sheppard, D C Mortimer.   

Abstract

Long-term bone calcium metabolism was measured using a whole body counter apparatus and the radioisotopes calcium-47 and strontium-85. Strontium was given with calcium in a single intravenous injection in order to estimate long-term retention of calcium. Calcium-47, with a short radio-active half-life, was measured directly for 20 days, and then indirectly from strontium retention for periods up to 200 days.The standard parameters of calcium transport were measured and, as well, a new parameter, calcium accretion to the fixed bone pool. These studies were carried out on 13 subjects, six of whom were selected "normals" and seven were patients with osteoporosis. Calcium accretion to the fixed bone pool, the new index of bone formation, varied from 100 to 210 mg. of calcium daily in normal subjects and from 70 to 340 mg./day in patients with osteoporosis. These values are one-third of those for the accretion to the total bone pool, the previously reported bone formation rate.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5933055      PMCID: PMC1935462     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  25 in total

1.  EFFECTS OF ANDROGENS, ESTROGENS AND HIGH CALCIUM INTAKES ON BONE FORMATION AND RESORPTION IN OSTEOPOROSIS.

Authors:  F W LAFFERTY; G E SPENCER; O H PEARSON
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

2.  The behavior of strontium-85 in a normal man following a single ingestion--absorption and excreation.

Authors:  M FUJITA; A YABE; K UENO; M OSHINO; N OKUYAMA
Journal:  Health Phys       Date:  1963-04       Impact factor: 1.316

3.  Quantitation of calcium metabolism. Theory.

Authors:  J P AUBERT; F BRONNER; L J RICHELLE
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

4.  Determination of bone formation rate with radioactive strontium.

Authors:  B E NORDIN; J MACGREGOR; M M BLUHM
Journal:  Clin Sci       Date:  1963-04       Impact factor: 6.124

5.  Skeletal dynamics in man measured by nonradioactive strontium.

Authors:  E EISENBERG; G S GORDAN
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

6.  Radiocalcium studies of bone formation rate in human metabolic bone disease.

Authors:  R P HEANEY; G D WHEDON
Journal:  J Clin Endocrinol Metab       Date:  1958-11       Impact factor: 5.958

7.  Accretion rate of bone salt in osteoporosis studied by means of P32.

Authors:  G C BAUER; A CARLSSON; B LINDQUIST
Journal:  Acta Med Scand       Date:  1957-08-13

8.  Utilization and intestinal excretion of calcium in man.

Authors:  M BLAU; H SPENCER; J SWERNOV; D LASZLO
Journal:  Science       Date:  1954-12-17       Impact factor: 47.728

9.  Human bone metabolism inferred from fall-out investigations.

Authors:  J Rivera
Journal:  Nature       Date:  1965-09-25       Impact factor: 49.962

10.  Strontium-90 in man. V.

Authors:  J L KULP; A R SCHULERT
Journal:  Science       Date:  1962-05-18       Impact factor: 47.728

View more
  5 in total

1.  [Studies on the metabolism of radium 224 (ThX) and estimation of radiation dosage during therapeutic application].

Authors:  R Grillmaier; H Muth; E Oberhausen
Journal:  Biophysik       Date:  1968

2.  Survival after massive small bowel resection.

Authors:  R Beaudry; A R Butson; J Harrison; J M Finlay
Journal:  Can Med Assoc J       Date:  1967-12-09       Impact factor: 8.262

3.  Direct measurement of osteolysis in man.

Authors:  J W Hansen; G S Gordan; S G Prussin
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

4.  Strontium substitution for calcium in lithogenesis.

Authors:  Sarah D Blaschko; Thomas Chi; Joe Miller; Lawrence Flechner; Sirine Fakra; Pankaj Kapahi; Arnold Kahn; Marshall L Stoller
Journal:  J Urol       Date:  2012-12-20       Impact factor: 7.450

5.  Complexes of myo-inositol-hexakisphosphate (InsP6) with zinc or lanthanum to enhance excretion of radioactive strontium from the body.

Authors:  Kazuma Ogawa; Miho Aoki; Sumi Kadono; Akira Odani
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.